A detailed history of Xponance, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Xponance, Inc. holds 119,858 shares of AMGN stock, worth $37.9 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
119,858
Previous 114,683 4.51%
Holding current value
$37.9 Million
Previous $32.6 Million 14.85%
% of portfolio
0.39%
Previous 0.35%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $1.36 Million - $1.65 Million
5,175 Added 4.51%
119,858 $37.4 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $804,727 - $971,408
2,993 Added 2.68%
114,683 $32.6 Million
Q4 2023

Jan 31, 2024

BUY
$255.7 - $288.46 $952,738 - $1.07 Million
3,726 Added 3.45%
111,690 $32.2 Million
Q3 2023

Oct 23, 2023

BUY
$218.65 - $271.46 $208,154 - $258,429
952 Added 0.89%
107,964 $29 Million
Q2 2023

Jul 13, 2023

SELL
$214.27 - $253.37 $1.8 Million - $2.13 Million
-8,397 Reduced 7.28%
107,012 $23.8 Million
Q1 2023

Apr 17, 2023

BUY
$225.79 - $275.2 $559,281 - $681,670
2,477 Added 2.19%
115,409 $27.9 Million
Q4 2022

Jan 23, 2023

BUY
$229.03 - $291.01 $2.28 Million - $2.89 Million
9,938 Added 9.65%
112,932 $0
Q3 2022

Oct 24, 2022

BUY
$224.46 - $253.15 $1.84 Million - $2.08 Million
8,203 Added 8.65%
102,994 $23.2 Million
Q2 2022

Aug 02, 2022

SELL
$230.71 - $256.74 $1.54 Million - $1.71 Million
-6,673 Reduced 6.58%
94,791 $23.1 Million
Q1 2022

Apr 20, 2022

BUY
$219.27 - $242.57 $28,943 - $32,019
132 Added 0.13%
101,464 $24.5 Million
Q4 2021

Jan 31, 2022

BUY
$198.88 - $227.6 $1.63 Million - $1.86 Million
8,189 Added 8.79%
101,332 $22.8 Million
Q3 2021

Nov 05, 2021

SELL
$212.27 - $248.7 $758,016 - $888,107
-3,571 Reduced 3.69%
93,143 $19.8 Million
Q2 2021

Aug 12, 2021

SELL
$233.58 - $259.14 $2.51 Million - $2.78 Million
-10,729 Reduced 9.99%
96,714 $23.6 Million
Q1 2021

May 10, 2021

SELL
$221.91 - $258.6 $51,926 - $60,512
-234 Reduced 0.22%
107,443 $26.7 Million
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $28,778 - $34,270
-133 Reduced 0.12%
107,677 $24.8 Million
Q3 2020

Oct 26, 2020

SELL
$234.65 - $260.95 $1.13 Million - $1.26 Million
-4,821 Reduced 4.28%
107,810 $27.4 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $22.3 Million - $27.3 Million
112,631 New
112,631 $26.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.